Your session is about to expire
← Back to Search
Home-Based Palliative Care for Kidney Failure (SHEPHERD 2 Trial)
N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be an adult (18 years of age or older) hospitalized at a Penn study hospital
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1- and 3-months
Awards & highlights
SHEPHERD 2 Trial Summary
This trial will evaluate if referrals to home palliative care services improve outcomes for patients with ESRD. Increasing access to these services could improve patient care.
Who is the study for?
This trial is for adults over 18 with End-Stage Renal Disease (ESRD) who've been hospitalized at a Penn hospital, live in the surrounding Philadelphia area, and show signs of needing more care at home. They shouldn't already be receiving palliative care but may have had multiple hospitalizations or other health issues like severe malnutrition.Check my eligibility
What is being tested?
The study tests if 'nudging' ESRD patients towards home palliative care services after they leave the hospital helps improve their quality of life compared to usual care without these extra services. It's about seeing if more support at home makes a difference.See study design
What are the potential side effects?
Since this trial involves referrals to supportive care rather than medication, there are no direct side effects from drugs. However, changes in healthcare management could affect patient comfort and well-being.
SHEPHERD 2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 or older and hospitalized at a Penn study hospital.
SHEPHERD 2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1- and 3-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1- and 3-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute Encounters
Secondary outcome measures
Health-Related Quality of Life
Home Palliative Care Visits
Hospice Enrollment
+5 moreSHEPHERD 2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The inpatient care team, including the attending/ordering and covering providers, for participants in this group will receive a message from the research team identifying their patient as appropriate for home palliative care and will be asked to refer their patient for these services.
Group II: Usual CareActive Control1 Intervention
Participants in this group will receive usual care upon discharge from the hospital. Their clinical team will not be notified that they are appropriate for home palliative care services, but they may still be referred for those services if their clinicians feel their patient will benefit.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,881,887 Total Patients Enrolled
2 Trials studying Kidney Failure
94,017 Patients Enrolled for Kidney Failure
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it currently possible to join this research endeavor?
"According to the clinicaltrials.gov listing, this medical trial is not currently enrolling patients as of November 16th 2023. Despite this setback, 637 other trials are actively searching for individuals who wish to participate in research studies at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger